Relay Therapeutics
RLAY
16.12
+0.21
+1.32%
Relay Therapeutics
US · RLAY
#2273 by market cap
Listed 2020
16.12
+0.21
+1.32%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
About Relay Therapeutics
Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.
- Founded
- 2015
- CEO
- Dr. Sanjiv K. Patel, M.B.B.S.,M.D.
- Employees
- 192
- Headquarters
- Cambridge, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- relaytx.com
Company profile
- Exchange
- US
- Symbol
- RLAY
- Market-cap rank
- #2273
- Listing date
- 2020-07-16
- Market cap
- 3.56B
- Float cap
- 2.49B
- Shares out
- 220.96M
- Float shares
- 154.74M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Relay Therapeutics discussion 0 comments